FDA inspection
Garaventa (Canada), Ltd.: FDA inspection ending May 9, 2024
FDA inspection 1238116 · Voluntary Action Indicated (VAI) · Surrey
Key facts
| Inspection ID | 1238116 |
|---|---|
| Firm | Garaventa (Canada), Ltd. |
| FEI number | 3002807131 |
| Address | 18920 36 Ave |
| City | Surrey |
| Country | Canada |
| Fiscal year | 2024 |
| Inspection end date | May 9, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data